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Abstract 
Background: In sepsis, tachycardia may indicate low preload, adrenergic stimulation, or both. Adrenergic overstimu-
lation is associated with septic cardiomyopathy. We sought to determine whether tachycardia was associated with left 
ventricular longitudinal strain, a measure of cardiac dysfunction. We hypothesized an association would primarily exist 
in patients with high preload.
Methods: We prospectively observed septic patients admitted to three study ICUs, who underwent early transtho-
racic echocardiography. We measured longitudinal strain using speckle tracking echocardiography and estimated 
preload status with an echocardiographic surrogate (E/e′). We assessed correlation between strain and heart rate in 
patients with low preload (E/e′ < 8), intermediate preload (E/e′ 8–14), and high preload (E/e′ > 14), adjusting for dis-
ease severity and vasopressor dependence.
Results: We studied 452 patients, of whom 298 had both measurable strain and preload. Abnormal strain (defined 
as >−17%) was present in 54%. Patients with abnormal strain had higher heart rates (100 vs. 93 beat/min, p = 0.001). 
After adjusting for vasopressor dependence, disease severity, and cardiac preload, we observed an association 
between heart rate and longitudinal strain (β = 0.05, p = 0.003). This association persisted among patients with high 
preload (β = 0.07, p = 0.016) and in patients with shock (β = 0.07, p = 0.01), but was absent in patients with low or 
intermediate preload and those not in shock.
Conclusions: Tachycardia is associated with abnormal left ventricular strain in septic patients with high preload. This 
association was not apparent in patients with low or intermediate preload.
Keywords: Strain, Echocardiography, Preload, Septic cardiomyopathy, Tachycardia
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Sepsis is a common and often lethal state of extreme 
disruption of homeostasis in the face of severe infection 
[1, 2]. Administration of exogenous catecholamines to 
maintain adequate arterial pressure is the cornerstone of 
current management of septic shock, despite the 20-fold 
increase in endogenous catecholamine levels observed 
in patients with septic shock [3] and increasing evidence 
for catecholamine toxicity as an important factor in sep-
tic shock physiology [4, 5]. This hyperadrenergic state, in 
combination with excess cytokine production, results in 
a spectrum of myocardial injury often grouped under the 
general category of septic cardiomyopathy. Septic car-
diomyopathy is remarkably common in sepsis, despite a 
historical belief that sepsis was primarily or exclusively 
a hyperdynamic state [5, 6]. Exogenous catecholamine 
therapy can improve myocardial contraction and is typi-
cally used to treat septic cardiomyopathy. However, cat-
echolamine administration may paradoxically worsen 
cardiac function [5]. In animals, infusion of epinephrine 
into coronary arteries induces a cardiomyopathy [7]. In 
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humans undergoing routine cardiac stress testing, dobu-
tamine infusions can directly induce cardiomyopathy 
[8–10].
Catecholamines are a key mediator of baroreflex func-
tion, by which the autonomic nervous system optimizes 
cardiac output and blood pressure through adjustments 
in heart rate, contractility, and vascular tone. Early in sep-
sis, tachycardia may merely reflect appropriate baroreflex 
activity [11]. In septic shock, however, the baroreflex sys-
tem often malfunctions. After adequate volume expan-
sion, persistent tachycardia in sepsis likely reflects an 
inappropriately hyperadrenergic state. In this respect, 
persistent tachycardia in septic shock may be similar to 
the excess tachycardia observed in stress cardiomyopathy 
[12]. Such persistent tachycardia is an independent risk 
factor for mortality in patients with sepsis [13–15]. The 
relationship between higher heart rate and poor outcome 
in established septic shock extends even to relatively low 
(<60–80/min) heart rates [16].
Historically, cardiac function in sepsis has been 
assessed primarily by left ventricular ejection fraction 
(LVEF). However, LVEF is highly load dependent and 
therefore less reliable in assessment of cardiac function 
in states of low preload or low afterload [17–21]. In the 
initial phase of septic shock, hypovolemia can occur with 
decreased preload and afterload related to increased cap-
illary leak [22] and low vascular resistance [23, 24]. The 
development of speckle tracking echocardiography has 
made possible the measurement of ventricular longitu-
dinal strain, a measure of deformation of the ventricu-
lar wall [25, 26]. Strain imaging has been demonstrated 
to detect subclinical myocardial dysfunction in animal 
models [27, 28], vigorously exercising healthy adults [29, 
30], and a number of disease states, including reduced 
preload or afterload states such as sepsis [26, 31–36].
Given the improved ability to detect septic cardiomyo-
pathy provided by the development of LV strain imaging 
techniques, we have a new opportunity to investigate the 
relationship between hyperadrenergic states in sepsis and 
septic cardiomyopathy. We hypothesized that in septic 
patients with adequate or increased preload, tachycardia 
would be associated with worse ventricular strain, sug-
gesting the possibility that hyperadrenergism, manifested 
by increased heart rate in the absence of low preload, is 
associated with septic cardiomyopathy, while tachycar-
dia in low-preload states would not be associated with 
impaired LV strain.
Methods
Study Design: This prospective, observational study 
was conducted at three intensive care units (ICUs) at 
two study hospitals, Intermountain Medical Center and 
Beth Israel Deaconess Medical Center. In these ICUs, 
transthoracic echocardiography (TTE) is routinely per-
formed on patients with sepsis or septic shock at the 
time of ICU admission. The protocol was approved by 
the Intermountain Healthcare Institutional Review Board 
with a waiver of informed consent and by the Beth Israel 
Deaconess Medical Center Institutional Review Board 
with oral informed consent.
Patients
We screened patients between October 2012 and Novem-
ber 2015 admitted with severe sepsis or septic shock 
defined by the then-current 1992 American College of 
Chest Physicians/Society of Critical Care Medicine con-
sensus criteria [37], and operationalized by recent large 
sepsis trials [38–40]. Patients met criteria for inclusion 
if they (1) were at least 18 years of age, (2) had clinically 
suspected infection, (3) had two or more systemic inflam-
matory response syndrome criteria, and (4) had either 
septic shock (systolic blood pressure <90 mmHg despite 
an intravenous fluid challenge of ≥20 ml/kg or infusion 
of any dose of vasopressor medications) or severe sepsis 
(defined in this study as serum lactate ≥4 mmol/L). An 
unrelated study of definitions of diastolic dysfunction 
[41] included 129 (28.5%) of the patient population we 
analyzed for the present study [41].
Clinical data
We calculated Acute Physiology and Chronic Health 
Evaluation, 2nd version (APACHE II) [42] and Sequen-
tial Organ Failure Assessment (SOFA) [43] scores at 
ICU admission for all patients. We determined receipt of 
mechanical ventilation and the vasopressor (norepineph-
rine, epinephrine, dopamine, phenylephrine, and vaso-
pressin) infusion rate at the time the echocardiogram 
was obtained. We converted the sum of vasopressor infu-
sion rates to norepinephrine-equivalent rates according 
to standard equivalencies [44]. We defined presence of 
shock based on vasopressor receipt at the time of echo 
[45]. We assessed both inpatient and 28-day mortality 
and calculated organ-failure-free days out of 14 days for 
the cardiovascular, coagulation, hepatic, and renal com-
ponents of the SOFA score. We recorded serum troponin 
in patients who had a clinically obtained serum troponin 
closest to the time of the echocardiogram, within 24  h. 
In patients enrolled in the Intermountain ICUs, we also 
recorded the amount of intravenous fluid administered in 
the 6 h preceding the echocardiogram.
Transthoracic echocardiography
Transthoracic echocardiograms (TTEs) were performed 
by a cardiac sonographer or a physician echocardiogra-
pher, using a Philips iE-33 or CX-50 (Philips Medical 
Systems, Bothell, WA). Patients were excluded if their 
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TTE occurred more than 24  h after ICU admission or 
if the image quality was so poor as to be uninterpret-
able. All echo readers were blinded to clinical outcomes, 
and all final interpretations were performed by Level II 
echocardiographers who are testamurs of the National 
Board of Echocardiography Adult Comprehensive Exam. 
Longitudinal strain was measured independently from 
preload assessment, to avoid possible bias. We used 
the Image-Arena platform (TomTec Imaging Systems, 
Unterschleissheim, Germany) to perform semiauto-
mated speckle tracking for left ventricular longitudinal 
strain. We selected standard apical four-chamber views 
for strain analysis. All strain analyses were performed 
by advanced cardiac sonographers or physicians who 
had already performed >100 h of speckle tracking analy-
sis. We selected the best available single cardiac cycle 
with regard to image quality and measured longitudi-
nal strain of the endocardium. We rejected images due 
to poor image quality if we could not track two or more 
adjacent segments in the apical four-chamber view. We 
defined abnormal strain as greater than −17% (higher 
numbers are worse) in accordance with previously pub-
lished literature describing patients with septic shock [20, 
46]. Because central venous pressure is no longer widely 
measured in the study ICUs, we defined cardiac preload 
using the ratio of early diastolic septal mitral inflow 
velocity to early diastolic mitral annulus velocity (E/e′) to 
assess left ventricular preload [41, 47, 48]. We defined a 
low-preload state as an E/e′ < 8, a high-preload state as 
>14, and an intermediate-preload state as 8–14 [49, 50]. 
In the subset of patients from the Intermountain ICUs, 
we formally categorized diastolic function in accordance 
with the 2016 American Society of Echocardiography 
guidelines [51].
Statistical analysis
Our prespecified primary analysis was a linear regression 
of LV longitudinal strain on heart rate, while controlling 
for vasopressor infusion rate, preload (E/e′), and admis-
sion APACHE II. To better understand the relevance 
of preload in this analysis, we secondarily fit separate 
regression models (controlling for vasopressor infusion 
rate and APACHE II) for patients with low preload, inter-
mediate preload, or high preload.
For purposes of description, we compared various 
patient characteristics and clinical outcomes according to 
preload status, shock status (receipt of vasopressors), and 
whether they met criteria for abnormal strain (>−17%). 
Low-, intermediate-, and high-preload patients were 
analyzed using Kruskal–Wallis tests for comparisons of 
central tendencies, while Wilcoxon rank sum tests were 
used to compare patients with and without shock, as well 
as those with and without abnormal strain. Fisher’s exact 
tests were used to compare proportions for all three anal-
yses. Statistical analyses were performed using the R Sta-
tistical Package, version 3.0.2 [52].
Results
Our study population comprised 452 patients, of whom 
392 (87%) had adequate echocardiographic image qual-
ity to measure longitudinal strain and 338 (75%) had 
a measureable E/e′ (Fig.  1). Seventy-eight percent of 
patients also met Sepsis-3 criteria [45]. We performed 
our primary analysis on the 298 patients who had both 
strain and E/e′ available. Echocardiograms were obtained 
quickly: median 2.3 h after ICU admission. Patient char-
acteristics are displayed in Table  1. The patients had a 
median SOFA score of 9 (IQR 6–12) and an APACHE 
II score of 25 (IQR 18–23), with an overall 28-day mor-
tality of 23%. At the time of the echocardiogram, 31% 
patients were undergoing mechanical ventilation and 
39% were in shock. Troponin was elevated (≥0.5 ng/mL) 
in 41% of patients (median 0.05 ng/mL, IQR 0.02–0.18). 
Patients with elevated troponin had worse strain (−14.6 
vs. −16.9, p =  0.04), but no difference in heart rate (97 
vs. 102, p  =  0.18). Fifty-four percent of the patients in 
the primary analysis had abnormal strain, and 36% had 
high preload (E/e′  >  14). Patients with abnormal strain 
had higher heart rates (100 vs. 93 beat/min, p = 0.001). 
We noted no difference between patients with shock and 
without shock in regard to heart rate (99 vs. 95, p = 0.88), 
ejection fraction (61% for both, p = 0.22), or strain (−16 
vs. −17%, p =  0.93). Patients in shock had a lower E/e′ 
(10.6, IQR 8.3–13.9) than those without shock (13.2, IQR 
9.6–18.6, p < 0.001). 
We observed no difference in heart rate among patients 
with low, intermediate, and high preload (median 100, 98, 
and 93 beat/min, p = 0.08). Patients with low preload had 
Fig. 1 Study inclusion and exclusion. E/e′: ratio of early diastolic 
mitral inflow blood velocity to early diastolic mitral annulus tissue 
velocity, a surrogate for ventricular preload
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lower stroke volume, and patients with higher preload 
received less fluid (Table 1). After adjusting for vasopres-
sor dosage, disease severity, and preload, we observed 
an association between heart rate and strain (β =  0.05, 
p  =  0.003, Table  2). In the stratified models based on 
low, intermediate, or high preload, we observed among 
patients with high preload an association between heart 
rate and longitudinal strain after adjusting for vasopres-
sor dosage and disease severity (β  =  0.07, p  =  0.016, 
Table  2; Fig.  2). This association was absent in patients 
with low preload (p  =  0.28) or intermediate preload 
(p =  0.19). In an exploratory analysis, we evaluated the 
expected negative correlation between ejection fraction 
and strain (r = −0.40 in low preload, −0.31 in interme-
diate preload, and −0.60 in high preload). We observed 
an association between ejection fraction and heart rate 
in patients with high preload (β  =  −0.22, p  =  0.002) 
that was absent in patients with low preload (p =  0.80) 
Table 1 Patient characteristics, categorized by preload
Preload was defined according to the ratio of early diastolic mitral filling to early mitral annular tissue velocity (E/e′)
APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, MAP mean arterial pressure, E/e′ ratio of early diastolic mitral 
inflow blood velocity to early diastolic mitral annular tissue velocity. OFFD organ-failure-free days
a Among those receiving vasopressors
b These data were only collected in the 398 patients from Intermountain ICUs, 40 with low preload, 146 with intermediate preload, 118 with high preload








 Female 240 (53%) 22 (39%) 78 (49%) 89 (74%) <0.001
 Age, years 65 (54–75) 59 (46–71) 64 (52–73) 71 (62–78) <0.001
 Body mass index 28 (24–34) 26 (24–31) 28 (24–33) 29 (25–33) 0.44
 APACHE II 25 (18–33) 29 (18–36) 24 (16–33) 24 (18–29) 0.10
 SOFA 9 (6–12) 9 (6–13) 9 (6–12) 8 (6–10) 0.09
 MAP, mm Hg 69 (61–77) 69 (65–77) 69 (61–76) 70 (60–76) 0.61
 Receiving vasopressors 175 (39%) 31 (54%) 74 (46%) 35 (29%) 0.001
 Norepinephrine-equivalent dose, mcg/kg/mina 0.14 (0.07–0.30) 0.17 (0.09–0.29) 0.15 (0.06–0.34) 0.09 (0.06–0.22) 0.23
 Mechanically ventilated 138 (31%) 31 (54%) 44 (28%) 24 (20%) <0.001
 PiO2/FiO2 ratio, mm Hg 234 (160–335) 223 (145–316) 248 (165–365) 250 (185–360) 0.66
 Serum lactate, mmol/dL 2.3 (1.4–3.8) 2.6 (1.5–4.0) 2.4 (1.5–3.9) 1.8 (1.2–3.5) 0.08
 Heart rate, BPM 97 (83–112) 100 (86–114) 98 (83–112) 93 (78–106) 0.08
 Fluid (6 h prior to echo), Lb 3.0 (1.2–4.0) 3.0 (1.9–4.8) 3.4 (2.0–5.0) 2.0 (1.0–4.0) 0.004
Echocardiographic parameters
 Ejection fraction, % 61 (52–69) 61 (50–70) 62 (56–67) 62.8 (52–70) 0.69
 Strain, % −17 (−20 to −12) −16 (−20 to 11) −17 (−20 to 13) −16 (−20 to 13) 0.38
 E/e′ 11.9 (8.9–16.3) 6.7 (5.9–7.4) 10.5 (9.4–12.2) 18.5 (15.7–21.8) <0.001
 Stroke volume, mL 56 (45–70) 48 (37–65) 61 (47–72) 60 (48–75) 0.015
Diastolic functionb <0.001
 Grade 0 (normal) 197 (49%) 26 (65%) 106 (72%) 16 (14%)
 Grade 1 23 (6%) 5 (13%) 12 (8%) 2 (2%)
 Grade 2 43 (11%) 1 (2%) 0 (0%) 40 (34%)
 Grade 3 16 (4%) 1 (2%) 1 (1%) 12 (10%)
 Indeterminate 119 (30%) 7 (18%) 27 (18%) 48 (41%)
Clinical outcomes
 Inpatient mortality 87 (19%) 14 (25%) 28 (18%) 21 (17%) 0.46
 28-Day mortality 103 (23%) 14 (25%) 33 (21%) 29 (24%) 0.73
 OFFD cardiovascular to day 14 13 (9–13) 12 (7–13) 13 (9–13) 13 (10–13) 0.08
 OFFD coagulation to day 14 14 (13–14) 14 (12–14) 14 (13–14) 14 (13–14) 0.98
 OFFD hepatic to day 14 14 (12–14) 14 (10–14) 14 (12–14) 14 (13–14) 0.50
 OFFD renal to day 14 13 (11–14) 13 (9–14) 13 (12–14) 13 (12–14) 0.39
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or intermediate preload (p = 0.87). We observed a simi-
lar association between strain and heart rate among 
patients with shock (β = 0.07, p = 0.01) that was absent 
in non-shock patients (Table 2). Additional clinical data 
on patients stratified by presence of shock are available 
(Additional file 1: Table S1).
In our secondary analysis of organ dysfunction, 
patients with normal LV strain had greater renal-failure-
free days than patients with abnormal strain (14 vs. 13, 
p = 0.01). We found no difference in hospital mortality or 
in cardiovascular-, hepatic-, or coagulation-failure-free 
days between patients with normal strain versus patients 
with abnormal strain (Table 3).
Discussion
In a large, multicenter cohort of septic patients undergo-
ing echocardiography, tachycardia was associated with 
worsened ventricular strain. This association persisted 
after adjusting for preload, vasopressor dose, and sever-
ity of illness. This association appeared to be restricted to 
patients with high preload, as estimated by an E/e′ > 14, 
a threshold normally associated with left arterial hyper-
tension. The observation that tachycardia in sepsis is 
associated with worsened clinical outcomes is well estab-
lished in the literature [14, 16, 53]. However, prior lit-
erature has not distinguished between tachycardia that 
likely represents a hyperadrenergic state, which may 
contribute to septic cardiomyopathy from tachycardia 
that likely reflects the adaptive response to low preload. 
Elevated heart rate may not be a simple surrogate for 
increased disease severity and increased receipt of vaso-
pressors [16]. Our study, which controlled for severity of 
illness and vasopressor infusion rates, demonstrates the 
importance of assessing cardiac preload when evaluat-
ing the implication of tachycardia in sepsis. The asso-
ciation between impaired strain and tachycardia adds 
further evidence to the evolving literature associating 
high adrenergic tone with septic cardiomyopathy [16, 
28, 54]. Some controversy exists regarding treatment 
of tachycardic septic patients with beta blocker therapy 
[55]. While our findings are too preliminary to be used to 
identify patients who might benefit from beta-blockade 
in sepsis, speckle tracking echocardiography may be of 
use in designing future investigations of beta-blockade in 
sepsis.
One challenge in discussing septic cardiomyopathy is 
that the term has been used to describe different patho-
physiologic states. Septic cardiomyopathy may refer to 
(a) decreased ejection fraction or stroke volume (which 
can occur with either high or low ejection fraction) [56], 
(b) new or worsened diastolic dysfunction [57, 58], and 
(c) cardiomyocyte dysfunction (including mitochondrio-
pathy, calcium handling, apoptosis, and hibernation) 
[59]. Some definitions of septic cardiomyopathy may thus 
be simple surrogate measures for cardiac filling pres-
sures or the severity of the underlying shock, while oth-
ers reflect intrinsic cardiomyocyte dysfunction. Our data 
suggest that when controlling for cardiac preload, a sensi-
tive measure of myocardial dysfunction is associated with 
tachycardia, itself a useful surrogate for hyperadrenergia.
Our proportion of patients with septic cardiomyopa-
thy compares similarly to other published cohorts [20, 
46, 60]. The use of longitudinal LV strain as the meas-
ure of left ventricular systolic function has advantages 
over LVEF, the historical measure. Despite being the 
common method to assess ventricular systolic function, 
LVEF varies with loading conditions and heart rate, is 
Table 2 Multivariable linear regression for  longitudinal 
LV strain among  patients, among  all patients, and  strati-
fied according to preload (E/e′) and according to presence 
of  shock (receiving a vasopressor at  the time of  echocar-
diogram)
APACHE II Acute Physiology and Chronic Health Evaluation, version 2, NEE 
norepinephrine-equivalent dose. TTE transthoracic echocardiogram
All patients with interpretable TTEs (N = 298) Coefficient p value
Heart rate 0.05 0.003
NEE during echo (per 0.01 mcg/kg/min increase) 0.02 0.17
APACHE II 0.03 0.37
E/e′ 0.11 0.02
Low preload E/e′ < 8 (N = 53)
 Heart rate −0.03 0.80
 NEE during echo (per 0.01 mcg/kg/min 
increase)
0.02 0.90
 APACHE II 0.12 0.56
Intermediate preload 8 ≤ E/e′ ≤ 14 (N = 135)
 Heart rate −0.01 0.87
 NEE during echo (per 0.01 mcg/kg/min 
increase)
0.005 0.86
 APACHE II 0.09 0.33
High preload E/e′ > 14 (N = 110)
 Heart rate −0.22 0.002
 NEE during echo (per 0.01 mcg/kg/min 
increase)
0.02 0.87
 APACHE II −0.02 0.87
Non-shock (N = 174)
 Heart rate 0.04 0.10
 APACHE II 0.06 0.20
 E/e′ 0.12 0.02
Shock (N = 124)
 Heart rate 0.07 0.01
 NEE during echo (per 0.01 mcg/kg/min 
increase)
0.02 0.36
 APACHE II −0.003 0.96
 E/e′ 0.04 0.70
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poorly reproducible for different observers, and is likely 
inferior to strain in representing intrinsic cardiac sys-
tolic function [34]. Our prior work in this area demon-
strated that ventricular strain was better associated with 
clinical measures of the adequacy of perfusion than LVEF 
[20]. However, on the basis of our stratified analysis, in 
patients with high preload, LVEF is associated with the 
degree of tachycardia. The correlation between strain and 
LVEF is moderate, suggesting that they measure differ-
ent aspects of myocardial function. As demonstrated in 
the effect plots and expected on the basis of prior stud-
ies, abnormal strain is more common than abnormal 
LVEF. We hypothesize that prior work has not adequately 
distinguished between an elevated LVEF that reflects 
low cardiac preload from an elevated LVEF that reflects 
an absence of septic cardiomyopathy. By controlling for 
cardiac preload, we may have allowed a more accurate 
assessment of the association between tachycardia and 
ventricular systolic dysfunction.
We acknowledge that E/e′ is an imperfect surrogate for 
left ventricular preload or hypovolemia [61]. Age, mitral 
valve disease, pericardial disease, mechanical ventilation, 
and regional wall motion abnormality all may affect the 
accuracy of E/e′. Our regression models included age as 
a component of APACHE II score, and a sensitivity analy-
sis including age as a separate covariate demonstrated age 
was not significantly associated with strain. Among criti-
cally ill patients, particularly an elevated E/e′ may be diffi-
cult to interpret. An increased E/e′ might reflect impaired 
myocardial diastolic function but could also result from 
hypervolemia with normal myocardial diastolic function. 
In addition, while E/e′ > 14 accurately identifies patients 
with high cardiac preload, E/e′  <  14 may be difficult to 
interpret [51]. While a low E/e′ is associated with lower 
filling pressures, a low E/e′ does not necessarily indicate 
hypovolemia. This large zone of uninterpretable values for 
E/e′ underlies the rejection of E/e′ as the sole measure of 
diastolic function in the ASE 2016 definitions, although 
use of the septal E/e′ as a sole measure of diastolic func-
tion has been studied in the critically ill [41]. In addition, 
we acknowledge that we employed septal E/e′ rather than 
the average of septal and lateral E/e′ due to image avail-
ability and based on previously published data suggesting 
adequate accuracy [48]. This may have made our meas-
urements of E/e′ more difficult to compare to values pub-
lished using the average of septal and lateral.
Alternative measures of assessing cardiac preload are 
available, although many have limitations, and there is 
no clinically available gold standard. In the contempo-
rary ICU, it is exceedingly uncommon to place pulmo-
nary artery catheters in septic patients to assess preload. 
Dynamic parameters such as pulse pressure variation, 
aortic velocity variation, or vena cava variation depend 
on passive mechanical ventilation, which is also uncom-
mon in contemporary ICUs [62]. The response to a pas-
sive leg raise (or similar provocative maneuvers like the 
expiratory occlusion test) [63] may have been informa-
tive, but was unfortunately not performed at the time of 
the echocardiogram in study patients.
Future scientific inquiry in this field may benefit from 
a composite of several available surrogates of cardiac 
preload, including dynamic parameters, passive leg raise, 
E/e′, shock index, and central venous pressure. A com-
posite of these measurements may outperform a single 
























Cutoff for abnormal strain
(Among patients with high preload)










Cutoff for abnormal EF
(Among patients with high preload)a b
Fig. 2 a Effect plot for heart rate and longitudinal strain; b effect plot for heart rate and ejection fraction among patients with high cardiac preload 
and controlling for vasopressor dose and APACHE II score. The plots depict thresholds for abnormal strain (−17%) and abnormal ejection fraction 
(45%) [46]
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surrogate measurement [64]. Perhaps more important, 
future studies would benefit from protocolized timing of 
echocardiography in relationship to fluid administration, 
perhaps immediately after receipt of the initial 30  ml/
kg volume expansion, and again immediately when sur-
rogates of cardiac preload indicate that the patient is no 
longer fluid responsive. Most studies in this field, includ-
ing the present study, have not dictated timing of echo-
cardiography at a specific phase of sepsis resuscitation, 
resulting in unnecessary heterogeneity. Our study was 
likely insufficiently powered to detect differences in mor-
tality, although there are other possible reasons for our 
failure to detect a mortality signal, such as confounding 
by severity of illness or therapeutic context. Based on our 
observations here, future studies in this field will likely 
require 750–1500 patients to exclude an association 
between strain and mortality, depending on the distribu-
tion of covariates.
Our study differs from other echocardiographic stud-
ies of septic patients in that the echoes were performed 
very early in the course of sepsis. Several other studies of 
septic patients performed echocardiography much later, 
around 24–48 h after the sepsis onset [19, 65–67]. Car-
diac dysfunction evolves over the course of sepsis resus-
citation [68], and our findings may not generalize to later 
sepsis. In our study, patients had all undergone initial vol-
ume resuscitation (median intravenous volume expan-
sion 3  L) preceding the echocardiogram. Additionally, 
39% were receiving vasopressors, which in themselves 
can negatively affect ventriculoarterial coupling and 
worsen ventricular function [68–70]. We did not have the 
data necessary to calculate ventriculoarterial uncoupling, 
Table 3 Clinical outcomes between normal and abnormal strain, stratified by preload status
Abnormal strain is defined as >−17% [46]
OFFD organ-failure-free days
Parameter Abnormal strain (n = 214) Normal strain (n = 178) p value
Overall
 Hospital mortality 47 (22%) 31 (17%) 0.31
 28-Day mortality 54 (25%) 36 (20%) 0.28
 OFFD to day 14—cardiovascular 13 (9–13) 12 (8–13) 0.37
 OFFD to day 14—coagulation 14 (13–14) 14 (13–14) 0.33
 OFFD to day 14—hepatic 14 (13–14) 14 (12–14) 0.71
 OFFD to day 14—renal 13 (10–14) 14 (13–14) 0.01
Low preload (E/e′ < 8) N = 33 N = 20
Hospital mortality 8 (24%) 5 (25%) 1.00
28-Day mortality 8 (24%) 4 (20%) 1.00
OFFD to day 14—cardiovascular 12 (9–13) 10 (7–13) 0.53
OFFD to day 14—coagulation 14 (13–14) 14 (11–14) 0.39
OFFD to day 14—hepatic 14 (13–14) 14 (3–14) 0.22
OFFD to day 14—renal 13 (9–14) 13 (11–14) 0.96
Intermediate preload (E/e′ 8–14) N = 66 N = 69
Hospital mortality 14 (21%) 12 (17%) 0.66
28-Day mortality 15 (23%) 15 (22%) 1.00
OFFD to day 14—cardiovascular 12 (9–13) 13 (8–13) 0.86
OFFD to day 14—coagulation 14 (11–14) 14 (13–14) 0.54
OFFD to day 14—hepatic 14 (11–14) 14 (12–14) 0.70
OFFD to day 14—renal 13 (9–14) 14 (13–14) 0.05
High preload (E/e′ > 14) N = 63 N = 47
Hospital mortality 13 (21%) 6 (13%) 0.32
28-Day mortality 18 (29%) 9 (19%) 0.27
OFFD to day 14—cardiovascular 13 (8–13) 13 (10–13) 0.97
OFFD to day 14—coagulation 14 (13–14) 14 (14–14) 0.14
OFFD to day 14—hepatic 14 (13–14) 14 (14–14) 0.13
OFFD to day 14—renal 13 (11–14) 14 (13–14) 0.22
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which may be relevant to cardiac dysfunction in sep-
sis. We observed that patients with higher preload had 
received less intravenous fluid prior to the echo. We 
hypothesize that patients with higher preload may not 
have responded to fluid resuscitation, resulting in clini-
cians adopting a fluid-conservative resuscitation strategy, 
while low-preload patients have received multiple vol-
ume expansions based on positive response to fluid.
The observed association between tachycardia and 
LV systolic dysfunction can be explained by multiple 
mechanisms. In low-preload states, tachycardia may be 
a compensatory response to reduced cardiac preload to 
maintain cardiac output [24]. However, in high-preload 
states, after initial therapy with intravenous volume 
expansion, high adrenergic tone may induce persistence 
of tachycardia [71] and contribute to cardiac dysfunction 
[57] while increasing myocardial oxygen consumption 
and decreasing diastolic filling and coronary perfusion 
[72, 73]. Our observation of decreased myocardial func-
tion in the setting of tachycardia and high preload sup-
ports this model and is the main contribution of this 
study.
It is possible that profound vasoplegia and its treat-
ment with vasoactive medications might be driving sep-
tic myocardial dysfunction [68, 74], although vasopressor 
dosage was not significant in our regression models. In 
such patients, there may be value in examining asso-
ciations between left ventricular hyperkinesis (LVEF 
>75%), strain, and preload. However, we only observed 
26 patients with LV hyperkinesis, limiting inferences in 
this population. We acknowledge that tachycardia in the 
absence of hypovolemia may result from pain, anemia, 
electrical conduction abnormalities, and hyperthyroid-
ism. While we were unable to measure pain, no patient 
had concomitant thyroid storm. Although 23% of study 
patients had a hemoglobin <7 g/dL at some point within 
24  h of the echo, all study ICUs typically transfuse to 
maintain hemoglobin >7 g/dL as a matter of practice.
One notable feature of tachycardia in sepsis is that 
the observed myocardial dysfunction may arise from 
a perturbation in the force–frequency and frequency-
dependent acceleration of relaxation (FDAR) mecha-
nisms, whereby tachycardia my worsen contractility due 
to decreased reuptake of calcium in the sarcoplasmic 
reticulum [59]. This mechanism may operate in parallel 
with toxic effects of hyperadrenergia. In other words, the 
association between tachycardia and impaired systolic 
function may reflect both direct effects of heart rate and 
common effects of high adrenergic tone.
While marked by a large sample size and echocardiog-
raphy performed during the early phase of sepsis most 
relevant to therapeutic interventions, our study never-
theless has limitations. Our definition of cardiac preload 
on the basis of LV diastolic filling patterns is an imper-
fect surrogate for left ventricular end-diastolic volume. 
E/e′ may be more representative of ventricular elastance 
than ventricular volumes per se. However, E/e′ has been 
demonstrated to correlate well with left ventricular end-
diastolic pressures and can be easily obtained in most 
patients with interpretable echo images [41, 47, 48]. 
Our definitions for severe sepsis and septic shock [37], 
although appropriate at the time of study and used in 
recent large trials of sepsis [38–40], have subsequently 
been replaced by the Sepsis-3 criteria [45]. Although 
78% percent of patients in this study also met Sepsis-3 
criteria, we lack information on non-enrolled patients 
who might have also met Sepsis-3 criteria. Therefore, 
this cohort of patients may not precisely match patients 
with sepsis defined by the new criteria. Patients in sep-
tic shock were receiving vasopressor infusions, which 
can worsen myocardial dysfunction, tachycardia, and 
strain [16, 68]. We did, however, adjust for vasopressor 
infusion rates in our analyses. About a third of eligible 
patients were excluded due to echocardiographic image 
quality, a well-known challenge in the critical care set-
ting [41]. Importantly, our cohort compares favorably 
with other clinical cohorts in critical care in terms of 
the proportion of interpretable echoes [20, 46, 60]. The 
study may be insufficiently powered to detect a rela-
tionship between strain and tachycardia in low-preload 
states, as considerably fewer patients had low preload. 
Current guidelines advocate early volume expansion, 
and it is possible that we might see a different distribu-
tion of cardiac preload if this study were conducted at 
later time in the course of resuscitation. Strengths of 
this multicenter study include its relatively large size, the 
capture of echocardiographic data early in the course of 
sepsis (2.3 h after ICU admission, on average), and that 
interpreters were blinded to clinical outcomes and read 
the strain and E/e′ components of the echo separately. 
The inclusion of both patients receiving and not receiv-
ing mechanical ventilation and vasopressor infusions 
also increases the generalizability of the study.
Conclusion
Tachycardia is associated with impaired LV strain, a sen-
sitive marker of cardiomyopathy, in septic patients with 
high cardiac preload.
Additional file
Additional file 1: Table S1. Patients stratified according to presence of 
shock (presence of vasopressor at time of echo) or no shock.
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